52
Last reporting period 31 Mar, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.01
Exchange
XBOM - Bombay Stock Exchange
0.09 B
Last period CFO ,INR
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Bharat Immunologicals
Company Analysis
524663.BO valuation, rating, competitors, insights and company profile
Eyestock Rating
524663.BO financial analysis by Eyestock methodology
Valuation
524663.BO valuation using historical relative method
Statements
524663.BO Income Statements, Balance Sheet and Cash Flow Statements
Dividends
524663.BO dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Bharat Immunologicals`s CFO for the period ended 2023-03-31 is 0.09 B INR
